Sirona Biochem Corp.
SRBCF
$0.01
$0.00-10.44%
OTC PK
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.96M | -1.71M | -1.97M | -1.88M | -1.69M |
| Total Depreciation and Amortization | 7.40K | 11.90K | 7.30K | 7.30K | 7.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 334.30K | 307.60K | 476.50K | 168.00K | 264.30K |
| Change in Net Operating Assets | 129.30K | -101.70K | -64.30K | 405.50K | 15.70K |
| Cash from Operations | -1.49M | -1.49M | -1.55M | -1.30M | -1.41M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 1.34M | 801.70K | 1.82M | 1.73M | 1.34M |
| Total Debt Repaid | -35.50K | -35.50K | 55.50K | -35.50K | -100.10K |
| Issuance of Common Stock | 289.60K | 217.10K | 30.00K | 52.50K | 52.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -26.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.17M | 724.00K | 1.40M | 1.29M | 933.30K |
| Foreign Exchange rate Adjustments | 111.00K | 109.10K | 110.30K | 116.40K | -147.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -205.30K | -658.40K | -31.90K | 102.50K | -620.30K |